Malaria Vaccines Market Report 2021 with Leading Key Players and Regional Analysis 2028

"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry analysis helps an organization formulate strategies and policies of a business."

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/37

Malaria is an infectious disease transmitted through mosquito bites. There are more than 400 different species of mosquitoes and they need only one species of disease to be able to infect humans. Mosquitoes lay their eggs on plants and animal droppings and they need the host plant to survive. In areas where there is an adequate water supply and climate, the risk of getting infected with malaria is very low, but it can be transferred by mosquitoes traveling in your household from one to another or by mosquitoes living in water or other stagnant places.

Global Malaria Vaccines Market: Drivers

High prevalence of malaria is expected to propel growth of the global malaria vaccines market over the forecast period. For instance, over 40% of the global population is at risk of malaria as per the World Health Organization.

Moreover, government initiatives to eliminate malaria is also expected to ad in growth of the market. For instance, The National Framework for Malaria Elimination (NFME) 2016-2030 outlines India's strategy for elimination of the disease by 2030.

Global Malaria Vaccines Market: Competitive Landscape

Major players operating in the global malaria vaccines market include, GenVec, Inc., GlaxoSmithKline plc, Nobelpharma Co., Ltd., Sanaria Inc., and Sumaya Biotech.

Global Malaria Vaccines Market: Opportunities

R&D of new vaccines is expected to offer lucrative growth opportunities for players in the global malaria vaccines market. For instance, in 2015, GSK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM in children aged 6 weeks to 17 months.

Global Malaria Vaccines Market: Recent Developments

Major players operating in the global malaria vaccines market are focused on offering affordable vaccines. For instance, in 2016, GSK announced plans to develop vaccines at a mere profit margin of 5% of the cost of the vaccine.

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/37

Covid-19 Impact Analysis:

Globally, as of 5:09 pm CEST, 20 October 2021, there have been 241,411,380 confirmed cases of COVID-19, including 4,912,112 deaths, reported to WHO. The World Health Organization stated that with the emergence of Covid-19, there is an urgent need to aggressively addressing the novel coronavirus while ensuring that other diseases, such as malaria, are not neglected. In November 2020, the WHO's World malaria report stated that there were gaps in access to life-saving tools that are undermining global efforts to curb malaria and the COVID-19 pandemic is expected to set back the fight even further.

Key Takeaways

The global malaria vaccines market is expected to reach US$ 50.6 million in 2024 at a CAGR of 150.0% during the forecast period (2024-2027). .Growth of the market is driven by high prevalence of malaria. For instance, there were around 214 million malaria cases reported in 2015, leading to 438,000 deaths worldwide. Over 70% of these deaths were among children under 5 years of age.

Among regions, Africa is expected to significant growth in the global malaria vaccines market, owing to high prevalence of malaria in the region. For instance, Sub-Saharan Africa accounts for the highest share of global malaria burden, with around 89% of malaria cases and 91% of malarial deaths in 2015. In 2017, Ghana recorded approximately 10.2 million suspected malaria cases in the out-patient department (OPD) in a population of some 30 million people, representing a 23-percent decrease over OPD malaria cases reported in 2016.

Asia Pacific is also expected to significant growth in the global malaria vaccines market, owing to high prevalence of malaria in the region. For instance, according to National Framework for Malaria Elimination , in 2012, the total economic burden of malaria in India was around US$ 1,940 Mn, with 75% from lost earnings and 25% from treatment costs borne by households.

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/37

Table of Content

1. Overview and Scope

1.1. Research goal & scope

1.2. Research assumptions

1.3. Research methodology

1.3.1. Primary data sources

1.3.2. Secondary data sources

1.4. Key takeaway

1.5. Stakeholders

2. Executive Summary

2.1. Market definition

2.2. Market segmentation

3. Malaria Vaccines Market Insights

3.1. Malaria Vaccines - Industry snapshot

3.1.1. Leading Companies

3.1.2. Key Companies to Watch

3.2. Malaria Vaccines - Ecosystem analysis

3.2.1. Market overview

3.2.2. Commercial Landscape

3.3. Malaria Vaccines Market Dynamics

3.3.1. Market Forces

3.3.1.1. Market Driver Analysis

3.3.1.2. Market Restraint/Challenges analysis

3.3.1.3. Market Opportunity Analysis

3.4. Industry analysis Porter's five forces

3.4.1. Bargaining power of supplier

3.4.2. Bargaining power of the buyer

3.4.3. Threat of substitute

3.4.4. The threat of new entrant

3.4.5. Degree of competition

3.5. Market PEST Analysis

3.6. Market Value Chain Analysis

3.7. Industry Trends

3.8. Competitive Ranking Analysis

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.